Immunome Inc.
IMNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472012
In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 8 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Immunome Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 114
- +12 vs. Q1 2024
- Shares held
- 47.8M
- +11.2M (+30.6%) vs. Q1 2024
- Total value
- $578.4M
- −$324.4M (−35.9%) vs. Q1 2024
- New holders
- 39
- 39 more added
- Sold out
- 27
- 22 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMNM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 202 | $2.50B |
| Q1 2026 | 202 | $2.54B |
| Q4 2025 | 183 | $2.54B |
| Q3 2025 | 153 | $1.07B |
| Q2 2025 | 142 | $738.7M |
| Q1 2025 | 143 | $518.4M |
| Q4 2024 | 121 | $566.3M |
| Q3 2024 | 115 | $754.7M |
| Q2 2024 | 114 | $578.4M |
| Q1 2024 | 103 | $903.6M |
| Q4 2023 | 57 | $229.9M |
| Q3 2023 | 35 | $19.7M |
| Q2 2023 | 35 | $15.4M |
| Q1 2023 | 30 | $9.34M |
| Q4 2022 | 28 | $4.85M |
| Q3 2022 | 24 | $10.7M |
| Q2 2022 | 26 | $7.78M |
| Q1 2022 | 29 | $15.4M |
| Q4 2021 | 30 | $36.4M |
| Q3 2021 | 35 | $58.3M |
| Q2 2021 | 29 | $41.1M |
| Q1 2021 | 31 | $64.7M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Immunome Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Woodline Partners LP | 922,892 | $11.2M | 0.11% | −395,164−30.0% | Reduced |
| Vestal Point Capital, LP | 1,000,000 | $12.1M | 0.90% | +1,000,000 | New |
| Geode Capital Management, LLC | 1,062,898 | $12.9M | 0.00% | +630,419+145.8% | Added |
| Opaleye Management Inc. | 1,102,500 | $13.3M | 3.05% | +1,102,500 | New |
| Marshall Wace, LLP | 1,713,325 | $20.7M | 0.03% | +1,191,774+228.5% | Added |
| Price T Rowe Associates Inc | 2,021,119 | $24.5M | 0.00% | −224,554−10.0% | Reduced |
| State Street Corp | 2,364,234 | $28.6M | 0.00% | +2,163,543+1,078.0% | Added |
| Vanguard Group Inc | 2,921,212 | $35.3M | 0.00% | +901,474+44.6% | Added |
| Janus Henderson Group PLC | 3,163,507 | $38.3M | 0.02% | +1,625,093+105.6% | Added |
| BlackRock Inc. | 3,758,864 | $45.5M | 0.00% | +2,929,851+353.4% | Added |
| T. Rowe Price Investment Management, Inc. | 3,878,595 | $46.9M | 0.03% | +2,362,141+155.8% | Added |
| EcoR1 Capital, LLC | 3,879,415 | $46.9M | 1.44% | 00.0% | Unchanged |
| FMR LLC | 4,210,943 | $51.0M | 0.00% | −323,700−7.1% | Reduced |
| Redmile Group, LLC | 4,889,554 | $59.2M | 3.58% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −594,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −465,286−100.0% | Sold out |
| Altitude Crest Partners Inc. | 0 | $0 | 0.00% | −262,284−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −133,438−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −132,500−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −127,980−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −102,954−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −69,305−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −44,853−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −43,400−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −42,300−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −34,991−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −31,878−100.0% | Sold out |
| Marathon Trading Investment Management LLC | 0 | $0 | 0.00% | −23,500−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −23,031−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −20,777−100.0% | Sold out |
| Ovata Capital Management Ltd | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Polymer Capital Management (HK) LTD | 0 | $0 | 0.00% | −12,726−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −10,536−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −8,740−100.0% | Sold out |
| Brighton Jones LLC | 0 | $0 | 0.00% | −8,477−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −7,489−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −4,255−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,165−100.0% | Sold out |
| KBC Group NV | 0 | $0 | 0.00% | −1,011−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −335−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −3,518−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |